Engerix-B

Engerix-B is a vaccine designed to prevent hepatitis B infection. It contains hepatitis B surface antigen (rDNA) and alum adjuvant. This vaccine is administered intramuscularly or subcutaneously.

Engerix-B is used to protect against hepatitis B virus infection. It is typically recommended for individuals at risk of exposure, such as healthcare workers, travelers to high-risk areas, and those with chronic liver disease. The vaccine works by stimulating the immune system to produce antibodies against the hepatitis B virus.

Common effects of Engerix-B may include soreness at the injection site, mild fever, and fatigue. These effects are usually temporary and resolve on their own. Severe reactions are rare but should be reported to a healthcare professional.

Engerix-B should be used with caution in individuals with a history of severe allergic reactions to yeast or any component of the vaccine. It is important to inform your healthcare provider about any medical conditions or allergies before receiving the vaccine.

Engerix-B may interact with certain medications that affect the immune system. It is advisable to consult a healthcare professional before taking other vaccines or medications concurrently. Alcohol and other immune-suppressing substances should be avoided around the time of vaccination.